The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting offered a compelling look into the future of cancer care—one that is increasingly shaped by innovation, data, and a deeper commitment to the patient experience. From artificial intelligence (AI) transforming...
The field of women’s oncology is undergoing one of its most transformative periods, driven by the rapid advancement of novel and targeted therapies. Treatment approaches are no longer “one-size-fits-all;” instead, care is increasingly guided by underlying tumor biology, enabling more...
Companion diagnostics (CDx) are transforming cancer care by guiding more precise, effective treatments for individual patients. As the foundation of precision medicine in oncology, CDx help identify who will benefit most from specific therapies—yet their development is shaped by complex...
The traditional entry point for clinical research organization (CRO) engagement is delivery of the first clinical research study. However, companies with limited internal resources may benefit from engaging with a CRO as early as possible to leverage the full breadth...
Over the past decade, significant advances have improved our understanding of the genetic and molecular mechanisms that lead to cancer.